S. Gujarathi et al. / Tetrahedron Letters 54 (2013) 3550–3553
3553
8. Lyle, F. R. U.S. Patent 5,973,257, 1985; Chem. Abstr. 1985, 65, 2870.
of nucleophiles, including 2-naphthol, 1,3-cyclohexanedione,
acetylacetone, methanol, ethylene glycol, anisole, amide, and
allyltrimethylsilane, were then tested under these reaction condi-
tions. Similarly, electron-donating p-MeO group on the phenyl ring
at the benzylic position of the propargylic alcohol was found to
have beneficial effects on reactivity compared to H atom and elec-
tron-withdrawing F atom on the same position (Table 2, entry g vs
entries h and i; entry j vs entry k). Complete regioselectivity was
observed with nucleophiles containing more than one electron-
rich carbon (2-naphthol, 1,3-cyclohexanedione, acetylacetone,
and anisole). In all cases, C-substitution was on the carbon with
the highest electron density, that is, C-1 for 2-naphthol, C-2 for
1,3-cyclohexanedione and acetylacetone, and C-4 for anisole.
In summary, we have developed a novel, efficient, and general
method for the direct nucleophilic substitution of the hydroxyl
group of propargylic alcohols with various nucleophiles using
Amberlite IR-120H resin as a catalyst. The method features short
reaction times, mild reaction conditions, simplicity in operation,
zero aqueous waste generation, complete regioselectivity, and a
clean reaction profile. Moreover, the resin is inexpensive, stable,
noncorrosive, easy to handle, and potentially reusable.
´
18. General experimental procedure: to a stirred mixture of arylpropargy alcohol 1
(1 mmol) and nucleophile (1.2 mmol) was added Amberlite IR-120H resin
(0.3 g) in acetonitrile (5 mL). The mixture was stirred at rt À60 °C (Table 1) for
an appropriate time. When the reaction was complete (GC and TLC analyses),
the mixture was filtered and evaporated to dryness in vacuo to yield the crude
product, which was purified by silicagel column chromatography (EtOAc-
hexane).
Acknowledgments
The authors would like to thank the College of Pharmacy of Uni-
versity of Arkansas for Medical Sciences for financial support and
Dr. Lin Song for the HRMS and HPLC analyses.
Spectral data for selected products: 3-(1-(4-methoxynaphthalen-1-yl)-3-
phenylprop-2-ynyl)-1H-indole (3d): solid; mp 150–152 °C; 1H NMR
(400 MHz, CDCl3): d 8.33 (bt, 1H), 8.19 (bt, 1H), 7.97 (s, 1H), 7.64 (dd, J = 8.0,
16.0 Hz, 2H), 7.41–7.49 (m, 4H), 7.36 (d, J = 8.0 Hz, 1H), 7.26 (br s, 3H), 7.19 (t,
J = 8.0 Hz, 1H), 7.08 (t, J = 8.0 Hz, 1H), 6.96 (s, 1H), 6.78 (d, J = 8.0 Hz, 1H), 6.08
(s, 1H), 4.02 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): d 154.9, 136.7, 131.7,
128.2, 128.1, 127.7, 126.5, 126.4, 126.1, 124.9, 124.0, 123.3, 122.6, 122.2, 119.8,
119.6, 116.6, 111.2, 103.3, 90.7, 55.5, 32.2 ppm; HRMS (ESI): m/z calcd for
References and notes
C
28H20NO [MÀH] 386.1545; found 386.1563. 3-(1-(1H-indol-3-yl)-3-
phenylprop-2-ynyl)-1-tosyl-1H-indole (3e): solid; mp: 129–131 °C; 1H NMR
(400 MHz, CDCl3): d 8.03 (br s, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.68 (d, J = 8.0 Hz,
2H), 7.64 (d, J = 8.0 Hz, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.49 (br s, 1H), 7.39–7.45
(m, 2H), 7.35 (d, J = 8.0 Hz, 1H), 7.24–7.31 (m, 4H), 7.14–7.20 (m, 5H), 7.04 (t,
J = 8.0 Hz, 1H), 5.59 (s, 1H), 2.27 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): d
144.8, 136.7, 135.7, 135.1, 131.7, 129.8, 129.7, 128.2, 128.0, 126.8, 125.9, 124.7,
124.3, 123.3, 123.1, 122.7, 122.3, 120.4, 119.5, 119.4, 114.2, 113.8, 111.4, 88.8,
82.7, 27.0, 21.5 ppm; HRMS (ESI): m/z calcd for C32H23N2O2S [MÀH] 499.1480;
found 499.1496. 1-(1-(4-methoxyphenyl)-3-phenylprop-2-ynyl)naphthalen-
2-ol (3g): solid; mp: 62–64 °C 1H NMR (400 MHz, CDCl3):
d 8.02 (d,
J = 8.4 Hz, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 8.0 Hz, 1H), 7.21–7.45 (m,
9H), 7.13 (d, J = 8.0 Hz, 1H), 6.81 (d, J = 7.3 Hz, 2H), 6.52 (s, 1H), 6.21 (s, 1H),
3.72 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): d 158.5, 152.2, 132.3, 131.8,
131.5, 129.7, 129.6, 128.8, 128.4, 128.3, 128.2, 126.8, 123.3, 123.0, 122.6, 119.1,
117.7, 114.0, 88.7, 85.7, 55.2, 32.9 ppm; HRMS (ESI): m/z calcd for C26H19O2
[MÀH] 363.1385; found 363.1381. 2-(1-(4-methoxynaphthalen-1-yl)-3-
phenylprop-2-ynyl)cyclohexane-1,3-dione (3m): solid; mp: 87–89 °C; 1H
NMR (400 MHz, CDCl3): d 8.31 (d, J = 8.0 Hz, 1H,), 8.05 (d, J = 8.0 Hz, 1H), 7.71
(d, J = 8.0 Hz, 1H), 7.38–7.59 (m, 5H), 7.24–7.33 (m, 2H), 6.77 (d, J = 8.0 Hz, 1H),
6.21 (s, 1H), 3.99 (s, 3H), 2.39–2.60 (m, 4H), 1.84–2.12 (m, 2H) ppm; 13C NMR
(100 MHz, CDCl3): d 196.2, 174.2, 155.5, 131.8, 131.7, 128.4, 128.3, 127.1,
126.7, 126.5, 125.5, 123.8, 123.8, 122.6, 122.6, 115.3, 102.8, 88.5, 88.4, 55.5,
36.5, 29.5, 27.9, 20.4 ppm; HRMS (ESI): m/z calcd for
C
26H21O3 [MÀH]
381.1490; found 381.1492. N-(1,3-diphenylprop-2-ynyl)-4-methylbenzamide
(3q): solid; mp: 146–148 °C; 1H NMR (100 MHz, CDCl3): d 7.72 (d, J = 8.0 Hz,
2H), 7.64 (d, J = 8.0 Hz, 2H), 7.23–7.48 (m, 8H), 7.21 (d, J = 7.6 Hz, 2H), 6.73 (d,
J = 8.4 Hz, 1H), 6.47 (d, J = 8.4 Hz, 1H), 2.38 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3): d 166.2, 142.4, 139.2, 131.9, 131.0, 129.3, 128.8, 128.6, 128.4, 128.2,
127.2, 122.5, 87.1, 85.0, 45.6, 21.5 ppm; HRMS (ESI): m/z calcd for C23H18NO
[MÀH] 324.1389; found 324.1372.